These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 4998693)

  • 21. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
    Cavun S; Göktalay G; Millington WR
    J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of behavioral and pharmacological history on the reinforcing effects of cocaine in rhesus monkeys.
    Nader MA
    NIDA Res Monogr; 1998 Mar; 169():26-55. PubMed ID: 9686410
    [No Abstract]   [Full Text] [Related]  

  • 23. Proceedings: The use of etorphine to induce self-injection behaviour in partially restrained rhesus monkeys.
    Berry PA; Lister RE
    Br J Pharmacol; 1974 Sep; 52(1):146P. PubMed ID: 4451797
    [No Abstract]   [Full Text] [Related]  

  • 24. Instrumental reflex reinforced with intragastric infusion of morphine.
    Cytawa J; Frydrychowski A; Luszawska D; Trojniar W
    Acta Physiol Pol; 1974 May; 25(3):285-8. PubMed ID: 4858367
    [No Abstract]   [Full Text] [Related]  

  • 25. L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; Insights towards selegiline's mechanism of action.
    He S; Grasing K
    Pharmacol Biochem Behav; 2006 Dec; 85(4):675-88. PubMed ID: 17157368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic analysis of the hypothermic responses of the morphine-dependent rhesus monkey.
    Holtzman SG; Villarreal JE
    J Pharmacol Exp Ther; 1971 May; 177(2):317-25. PubMed ID: 4998695
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of naloxone and nalorphine during the development of morphine dependence in rhesus monkeys.
    Aceto MD; Flora RE; Harris LS
    Pharmacology; 1977; 15(1):1-9. PubMed ID: 402658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of morphine, naloxone, and diallylnormorphine upon behaviour maintained by electric-shock postponement in squirrel monkeys.
    Stretch R; Sanchez-Ramos JR
    Can J Physiol Pharmacol; 1979 Jan; 57(1):98-105. PubMed ID: 106942
    [No Abstract]   [Full Text] [Related]  

  • 29. Naltrexone effects on morphine and food self-administration in morphine-dependent rhesus monkeys.
    Mello NK; Mendelson JH; Bree MP
    J Pharmacol Exp Ther; 1981 Aug; 218(2):550-7. PubMed ID: 7195937
    [No Abstract]   [Full Text] [Related]  

  • 30. Classification of narcotics on the basis of their reinforcing, discriminative, and antagonist effects in rhesus monkeys.
    Woods JH; Young AM; Herling S
    Fed Proc; 1982 Feb; 41(2):221-7. PubMed ID: 7037459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 23. Morphine as a reinforcing agent: laboratory studies of its capacity to change behavior.
    Nichols JR
    Res Publ Assoc Res Nerv Ment Dis; 1968; 46():299-310. PubMed ID: 5723799
    [No Abstract]   [Full Text] [Related]  

  • 32. An investigation of nalorphine and perphenazine as negative reinforcers in an escape paradigm.
    Kandel DA; Schuster CR
    Pharmacol Biochem Behav; 1977 Jan; 6(1):61-71. PubMed ID: 403529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychological approaches to opiate dependence and self-administration by laboratory animals.
    Schuster CR
    Fed Proc; 1970; 29(1):2-5. PubMed ID: 4983813
    [No Abstract]   [Full Text] [Related]  

  • 34. A single-dose suppression test in morphine-dependent mice.
    Takemori AE; Stesin AJ; Tulunay FC
    Proc Soc Exp Biol Med; 1974 Apr; 145(4):1232-5. PubMed ID: 4406488
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduction of conditioned suppression: actions of morphine compared with those of amphetamine, pentobarbital, nalorphine, cocaine, LSD-25 and chlorpromazine.
    Hill HE; Bell EC; Wikler A
    Arch Int Pharmacodyn Ther; 1967 Jan; 165(1):212-26. PubMed ID: 6030238
    [No Abstract]   [Full Text] [Related]  

  • 36. Repeated administration of dopaminergic agents in the nucleus accumbens and morphine-induced place preference.
    Zarrindast MR; Azami BN; Rostami P; Rezayof A
    Behav Brain Res; 2006 May; 169(2):248-55. PubMed ID: 16472879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. History of drug exposure as a determinant of drug self-administration.
    Young AM; Herling S; Woods JH
    NIDA Res Monogr; 1981 Jul; 37():75-88. PubMed ID: 6798469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electroencephalographic characteristics of narcotic antagonists.
    Navarro G; Elliott HW
    Proc West Pharmacol Soc; 1969; 12():96-8. PubMed ID: 5812311
    [No Abstract]   [Full Text] [Related]  

  • 39. Changes in fixed-interval behavior during chronic morphine treatment and morphine abstinence in rats.
    Babbini M; Gaiardi M; Bartoletti M
    Psychopharmacologia; 1976 Feb; 45(3):255-9. PubMed ID: 943119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirements for extinction of relapse-facilitating variables and for rehabilitation in a narcotic-antagonist treatment program.
    Wikler A
    Adv Biochem Psychopharmacol; 1973; 8(0):399-414. PubMed ID: 4795072
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.